<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39255369</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1944-0057</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>Food additives &amp; contaminants. Part A, Chemistry, analysis, control, exposure &amp; risk assessment</Title><ISOAbbreviation>Food Addit Contam Part A Chem Anal Control Expo Risk Assess</ISOAbbreviation></Journal><ArticleTitle>Determination of azodicarbonamide in flour samples using high-performance liquid chromatography-tandem mass spectrometry with xanthydrol pre-column derivatisation.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>11</EndPage><MedlinePgn>1-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/19440049.2024.2400238</ELocationID><Abstract><AbstractText>Azodicarbonamide (ADA) is approved as a food additive in flour products due to its oxidising and bleaching properties. However, it is prohibited in Australia and Europe on account of its toxicity and the risk of causing asthma in humans. A method was developed to determine ADA in actual flour samples. This work presents an optimised methodology based on derivatisation and clean-up procedures followed by ultra-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry (UPLC-ESI-MS/MS). The analytical method was successfully validated. An excellent result was obtained for the linearity of matrix-matched calibration curves (<i>R</i><sup>2</sup>&#x2009;&gt;&#x2009;0.99) in the concentration range of 0.10-80&#x2009;mg/kg. The recovery rate varied from 81.7% to 102.3%. The relative standard deviations (RSDs) of repeatability (<i>n</i>&#x2009;=&#x2009;6) were 1.3-4.1%, and inter-day RSDs (<i>n</i>&#x2009;=&#x2009;6) were 2.2-4.8%. The limit of detection and the limit of quantification were 0.014 and 0.042&#x2009;mg/kg, which were significantly lower than the requirement of 45&#x2009;mg/kg stipulated in the Chinese National Food Safety Standard (GB 2760-2014). The detection rate of ADA in 26 flour samples was 23.1%, with the concentration ranging from 0.023 to 23.2&#x2009;mg/kg.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Taizhou Center for Disease Prevention and Control, Taizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Huamei</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1771-9906</Identifier><AffiliationInfo><Affiliation>Taizhou Center for Disease Prevention and Control, Taizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Wenliang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Center for Disease Prevention and Control, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Food Addit Contam Part A Chem Anal Control Expo Risk Assess</MedlineTA><NlmUniqueID>101485040</NlmUniqueID><ISSNLinking>1944-0057</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Azodicarbonamide</Keyword><Keyword MajorTopicYN="N">UPLC&#x2013;MS/MS</Keyword><Keyword MajorTopicYN="N">derivation</Keyword><Keyword MajorTopicYN="N">flour</Keyword><Keyword MajorTopicYN="N">xanthydrol</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>14</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39255369</ArticleId><ArticleId IdType="doi">10.1080/19440049.2024.2400238</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>